464 related articles for article (PubMed ID: 34188447)
1. Prospective Application of Two New Pyridine-Based Zinc (II) Amide Carboxylate in Management of Alzheimer's Disease: Synthesis, Characterization, Computational and in vitro Approaches.
Zafar R; Naureen H; Zubair M; Shahid K; Saeed Jan M; Akhtar S; Ahmad H; Waseem W; Haider A; Ali S; Tariq M; Sadiq A
Drug Des Devel Ther; 2021; 15():2679-2694. PubMed ID: 34188447
[TBL] [Abstract][Full Text] [Related]
2. Zinc metal carboxylates as potential anti-Alzheimer's candidate:
Zafar R; Zubair M; Ali S; Shahid K; Waseem W; Naureen H; Haider A; Jan MS; Ullah F; Sirajuddin M; Sadiq A
J Biomol Struct Dyn; 2021 Feb; 39(3):1044-1054. PubMed ID: 32013770
[TBL] [Abstract][Full Text] [Related]
3. Comparative chemical profiling, cholinesterase inhibitions and anti-radicals properties of essential oils from Polygonum hydropiper L: a preliminary anti- Alzheimer's study.
Ayaz M; Junaid M; Ullah F; Sadiq A; Khan MA; Ahmad W; Shah MR; Imran M; Ahmad S
Lipids Health Dis; 2015 Nov; 14():141. PubMed ID: 26530857
[TBL] [Abstract][Full Text] [Related]
4. Comparative Cholinesterase, α-Glucosidase Inhibitory, Antioxidant, Molecular Docking, and Kinetic Studies on Potent Succinimide Derivatives.
Ahmad A; Ullah F; Sadiq A; Ayaz M; Saeed Jan M; Shahid M; Wadood A; Mahmood F; Rashid U; Ullah R; Sahibzada MUK; Alqahtani AS; Mahmood HM
Drug Des Devel Ther; 2020; 14():2165-2178. PubMed ID: 32606589
[TBL] [Abstract][Full Text] [Related]
5. Conjugates of tacrine and 1,2,4-thiadiazole derivatives as new potential multifunctional agents for Alzheimer's disease treatment: Synthesis, quantum-chemical characterization, molecular docking, and biological evaluation.
Makhaeva GF; Kovaleva NV; Boltneva NP; Lushchekina SV; Rudakova EV; Stupina TS; Terentiev AA; Serkov IV; Proshin AN; Radchenko EV; Palyulin VA; Bachurin SO; Richardson RJ
Bioorg Chem; 2020 Jan; 94():103387. PubMed ID: 31735356
[TBL] [Abstract][Full Text] [Related]
6. Bis-Amiridines as Acetylcholinesterase and Butyrylcholinesterase Inhibitors:
Makhaeva GF; Kovaleva NV; Boltneva NP; Rudakova EV; Lushchekina SV; Astakhova TY; Serkov IV; Proshin AN; Radchenko EV; Palyulin VA; Korabecny J; Soukup O; Bachurin SO; Richardson RJ
Molecules; 2022 Feb; 27(3):. PubMed ID: 35164325
[TBL] [Abstract][Full Text] [Related]
7. Design, Synthesis, and Molecular Docking of Some Novel Tacrine Based Cyclopentapyranopyridine- and Tetrahydropyranoquinoline-Kojic Acid Derivatives as Anti-Acetylcholinesterase Agents.
Babaee S; Chehardoli G; Akbarzadeh T; Zolfigol MA; Mahdavi M; Rastegari A; Homayouni Moghadam F; Najafi Z
Chem Biodivers; 2021 Jun; 18(6):e2000924. PubMed ID: 33861892
[TBL] [Abstract][Full Text] [Related]
8. Amiridine-piperazine hybrids as cholinesterase inhibitors and potential multitarget agents for Alzheimer's disease treatment.
Makhaeva GF; Lushchekina SV; Kovaleva NV; Yu Astakhova T; Boltneva NP; Rudakova EV; Serebryakova OG; Proshin AN; Serkov IV; Trofimova TP; Tafeenko VA; Radchenko EV; Palyulin VA; Fisenko VP; Korábečný J; Soukup O; Richardson RJ
Bioorg Chem; 2021 Jul; 112():104974. PubMed ID: 34029971
[TBL] [Abstract][Full Text] [Related]
9. 9-Substituted acridine derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors possessing antioxidant activity for Alzheimer's disease treatment.
Makhaeva GF; Lushchekina SV; Boltneva NP; Serebryakova OG; Rudakova EV; Ustyugov AA; Bachurin SO; Shchepochkin AV; Chupakhin ON; Charushin VN; Richardson RJ
Bioorg Med Chem; 2017 Nov; 25(21):5981-5994. PubMed ID: 28986116
[TBL] [Abstract][Full Text] [Related]
10. Pyridine sulfonamide as a small key organic molecule for the potential treatment of type-II diabetes mellitus and Alzheimer's disease: In vitro studies against yeast α-glucosidase, acetylcholinesterase and butyrylcholinesterase.
Riaz S; Khan IU; Bajda M; Ashraf M; Qurat-Ul-Ain ; Shaukat A; Rehman TU; Mutahir S; Hussain S; Mustafa G; Yar M
Bioorg Chem; 2015 Dec; 63():64-71. PubMed ID: 26451651
[TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of some new carboxamide and propanamide derivatives bearing phenylpyridazine as a core ring and the investigation of their inhibitory potential on in-vitro acetylcholinesterase and butyrylcholinesterase.
Kilic B; Gulcan HO; Aksakal F; Ercetin T; Oruklu N; Umit Bagriacik E; Dogruer DS
Bioorg Chem; 2018 Sep; 79():235-249. PubMed ID: 29775949
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and Biological Activity of Some Benzochromenoquinolinones: Tacrine Analogs as Potent Anti-Alzheimer's Agents.
Mahdavi M; Hariri R; Mirfazli SS; Lotfian H; Rastergari A; Firuzi O; Edraki N; Larijani B; Akbarzadeh T; Saeedi M
Chem Biodivers; 2019 Apr; 16(4):e1800488. PubMed ID: 30720917
[TBL] [Abstract][Full Text] [Related]
13. Acetyl- and butyryl-cholinesterase inhibitory activities of the edible brown alga Eisenia bicyclis.
Choi JS; Haulader S; Karki S; Jung HJ; Kim HR; Jung HA
Arch Pharm Res; 2015 Aug; 38(8):1477-87. PubMed ID: 25370610
[TBL] [Abstract][Full Text] [Related]
14. New 4-N-phenylaminoquinoline derivatives as antioxidant, metal chelating and cholinesterase inhibitors for Alzheimer's disease.
Cai R; Wang LN; Fan JJ; Geng SQ; Liu YM
Bioorg Chem; 2019 Dec; 93():103328. PubMed ID: 31600664
[TBL] [Abstract][Full Text] [Related]
15. Novel Pyridine-Containing Sultones: Structure-Activity Relationship and Biological Evaluation as Selective AChE Inhibitors for the Treatment of Alzheimer's disease.
Zhang H; Wu C; Chen X; Zhang Z; Jiang X; Qin HL; Tang W
ChemMedChem; 2021 Oct; 16(20):3189-3200. PubMed ID: 34036731
[TBL] [Abstract][Full Text] [Related]
16. Interest of novel N-alkylpyridinium-indolizine hybrids in the field of Alzheimer's disease: Synthesis, characterization and evaluation of antioxidant activity, cholinesterase inhibition, and amyloid fibrillation interference.
Baussanne I; Firstova O; Dediu AB; Larosa C; Furdui B; Ghinea IO; Thomas A; Chierici S; Dinica R; Demeunynck M
Bioorg Chem; 2021 Nov; 116():105390. PubMed ID: 34670332
[TBL] [Abstract][Full Text] [Related]
17. Design, Synthesis and Biological Evaluation of Xanthone Derivatives for Possible Treatment of Alzheimer's Disease Based on Multi-Target Strategy.
Yang A; Yu Q; Ju H; Song L; Kou X; Shen R
Chem Biodivers; 2020 Oct; 17(10):e2000442. PubMed ID: 32692899
[TBL] [Abstract][Full Text] [Related]
18. Thieno[2,3-b]pyridine amines: Synthesis and evaluation of tacrine analogs against biological activities related to Alzheimer's disease.
Saeedi M; Safavi M; Allahabadi E; Rastegari A; Hariri R; Jafari S; Bukhari SNA; Mirfazli SS; Firuzi O; Edraki N; Mahdavi M; Akbarzadeh T
Arch Pharm (Weinheim); 2020 Oct; 353(10):e2000101. PubMed ID: 32657467
[TBL] [Abstract][Full Text] [Related]
19. Exploration of dual fatty acid amide hydrolase and cholinesterase inhibitory potential of some 3-hydroxy-3-phenacyloxindole analogs.
Tripathi RKP; Ayyannan SR
Arch Pharm (Weinheim); 2020 Sep; 353(9):e2000036. PubMed ID: 32573008
[TBL] [Abstract][Full Text] [Related]
20. Further SAR studies on natural template based neuroprotective molecules for the treatment of Alzheimer's disease.
Singh YP; Shankar G; Jahan S; Singh G; Kumar N; Barik A; Upadhyay P; Singh L; Kamble K; Singh GK; Tiwari S; Garg P; Gupta S; Modi G
Bioorg Med Chem; 2021 Sep; 46():116385. PubMed ID: 34481338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
